Patient
SITE007-0122
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2026-01-20
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-31 (study day 182); relationship: not assessed
Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-01-20 (study day 171); relationship: not assessed
Grade 3 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-01-17 (study day 168); relationship: NOT RELATED
Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-01-16 (study day 167); relationship: NOT RELATED
Grade 1 Pruritus — outcome: RECOVERED/RESOLVED; onset 2022-11-25 (study day 115); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.